146 related articles for article (PubMed ID: 7783827)
1. Hyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure?
Janssen MJ; van den Berg M; Stehouwer CD; Boers GH
Neth J Med; 1995 May; 46(5):244-51. PubMed ID: 7783827
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine - a new arteriosclerotic risk factor in end-stage renal failure.
Zidek W
Nephron; 1997; 75(3):249-50. PubMed ID: 9069443
[No Abstract] [Full Text] [Related]
3. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
[TBL] [Abstract][Full Text] [Related]
4. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
5. Evidence of altered homocysteine metabolism in chronic renal failure.
Henning BF; Riezler R; Tepel M; Langer K; Raidt H; Graefe U; Zidek W
Nephron; 1999; 83(4):314-22. PubMed ID: 10575293
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the presence of premature atherosclerosis in adults with heterozygosity for cystathionine-beta-synthase deficiency.
de Valk HW; van Eeden MK; Banga JD; van der Griend R; de Groot E; Haas FJ; Meuwissen OJ; Duran M; Smeitink JA; Poll-The BT; de Klerk JB; Wittebol-Post D; Rolland MO
Stroke; 1996 Jun; 27(6):1134-6. PubMed ID: 8650730
[No Abstract] [Full Text] [Related]
7. Transsulphuration and methylation of homocysteine in control and mutant human fibroblasts.
Fowler B
Biochim Biophys Acta; 1982 Oct; 721(2):201-7. PubMed ID: 7138917
[TBL] [Abstract][Full Text] [Related]
8. Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis.
Maclean KN; Jiang H; Phinney WN; Mclagan BM; Roede JR; Stabler SP
Mol Genet Metab; 2021 Feb; 132(2):128-138. PubMed ID: 33483253
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
10. Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.
Wilcken DE; Dudman NP; Tyrrell PA
Metabolism; 1985 Dec; 34(12):1115-21. PubMed ID: 3934499
[TBL] [Abstract][Full Text] [Related]
11. Cystathionine-beta-synthase deficiency: detection of heterozygotes by the ratios of homocysteine to cysteine and folate.
Boddie AM; Steen MT; Sullivan KM; Pasquali M; Dembure PP; Coates RJ; Elsas LJ
Metabolism; 1998 Feb; 47(2):207-11. PubMed ID: 9472972
[TBL] [Abstract][Full Text] [Related]
12. When to measure plasma homocysteine and how to place it in context: The homocystinurias.
Huemer M
J Mother Child; 2020 Oct; 24(2):39-46. PubMed ID: 33179601
[TBL] [Abstract][Full Text] [Related]
13. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
[TBL] [Abstract][Full Text] [Related]
14. Effect of methionine and nitrous oxide on homocysteine export and remethylation in fibroblasts from cystathionine synthase-deficient, cb1G, and cb1E patients.
Christensen B; Rosenblatt DS; Chu RC; Ueland PM
Pediatr Res; 1994 Jan; 35(1):3-9. PubMed ID: 8134195
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency.
Dudman NP; Wilcken DE
Clin Chim Acta; 1983 Jan; 127(1):105-13. PubMed ID: 6825304
[TBL] [Abstract][Full Text] [Related]
16. Genetic determinants of hyperhomocysteinaemia: the roles of cystathionine beta-synthase and 5,10-methylenetetrahydrofolate reductase.
Blom HJ
Eur J Pediatr; 2000 Dec; 159 Suppl 3():S208-12. PubMed ID: 11216902
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function.
Wilcken DE; Wang J; Sim AS; Green K; Wilcken B
J Inherit Metab Dis; 2006 Feb; 29(1):30-7. PubMed ID: 16601865
[TBL] [Abstract][Full Text] [Related]
18. Homocystinuria: pathogenetic mechanisms.
Grieco AJ
Am J Med Sci; 1977; 273(2):120-32. PubMed ID: 324277
[TBL] [Abstract][Full Text] [Related]
19. Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype.
Guttormsen AB; Ueland PM; Kruger WD; Kim CE; Ose L; Følling I; Refsum H
Am J Med Genet; 2001 May; 100(3):204-13. PubMed ID: 11343305
[TBL] [Abstract][Full Text] [Related]
20. Homocysteinemia and vascular disease in end-stage renal disease.
Dennis VW; Robinson K
Kidney Int Suppl; 1996 Dec; 57():S11-7. PubMed ID: 8941916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
